Audit 344842

FY End
2024-06-30
Total Expended
$47.48M
Findings
0
Programs
32
Year: 2024 Accepted: 2025-03-05
Auditor: Windes INC

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
10.557 Wic Special Supplemental Nutrition Program for Women, Infants, and Children $10.70M Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $670,288 Yes 0
93.121 Oral Diseases and Disorders Research $584,879 Yes 0
93.127 Emergency Medical Services for Children $251,160 Yes 0
93.865 Child Health and Human Development Extramural Research $173,319 Yes 0
93.185 Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects $127,922 Yes 0
93.213 Research and Training in Complementary and Integrative Health $117,084 Yes 0
93.839 Blood Diseases and Resources Research $97,222 Yes 0
93.279 Drug Use and Addiction Research Programs $92,075 Yes 0
93.107 Area Health Education Centers $87,405 Yes 0
93.889 National Bioterrorism Hospital Preparedness Program $75,730 Yes 0
93.242 Mental Health Research Grants $56,140 Yes 0
93.310 Trans-Nih Research Support $50,307 Yes 0
93.273 Alcohol Research Programs $46,449 Yes 0
93.859 Biomedical Research and Research Training $45,853 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $38,180 Yes 0
93.866 Aging Research $33,530 Yes 0
93.307 Minority Health and Health Disparities Research $32,855 Yes 0
93.226 Research on Healthcare Costs, Quality and Outcomes $26,335 Yes 0
93.867 Vision Research $24,489 Yes 0
93.000 Minority Health and Health Disparities Research $20,612 Yes 0
12.420 Military Medical Research and Development $20,293 Yes 0
93.233 National Center on Sleep Disorders Research $17,395 Yes 0
93.113 Environmental Health $16,428 Yes 0
93.110 Maternal and Child Health Federal Consolidated Programs $15,925 Yes 0
47.070 Computer and Information Science and Engineering $15,106 Yes 0
93.838 Lung Diseases Research $6,676 Yes 0
93.837 Cardiovascular Diseases Research $5,647 Yes 0
93.172 Human Genome Research $5,250 Yes 0
93.393 Cancer Cause and Prevention Research $4,511 Yes 0
93.350 National Center for Advancing Translational Sciences $2,525 Yes 0
93.855 Allergy and Infectious Diseases Research $-47,018 Yes 0

Contacts

Name Title Type
LTJVF4QSFCP9 Melissa Zak Auditee
3104084372 Kelly Buck Auditor
No contacts on file

Notes to SEFA

Title: NOTE 1 – Basis of Presentation Accounting Policies: Expenditures on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts reflected in the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (the Institute), formerly known as Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, is an independent biomedical research institute. The accompanying schedule of expenditures of federal awards (the Schedule) is prepared on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the basic financial statements.
Title: NOTE 2 – Summary of Significant Accounting Policies Accounting Policies: Expenditures on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts reflected in the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. Expenditures on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts reflected in the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years.
Title: NOTE 3 – Indirect Cost Rate Accounting Policies: Expenditures on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts reflected in the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. The Institute has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance.